| Business

Become a contributor

Bookmark Econotimes

| Business

Samsung Electronics Shares Jump on HBM4 Mass Production Report

Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape

American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns

Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units

Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion

Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning

Anta Sports Expands Global Footprint With Strategic Puma Stake

TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans

DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins

Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal

Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing

Amazon Explores AI Content Marketplace With Media Publishers

FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns

Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade

Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate

Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible

Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge

©Econometrics LLC . All Rights Reserved.

Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018

Thursday, February 22, 2018 10:59 PM UTC

MEDFORD, N.Y., Feb. 22, 2018 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the fourth quarter and full year 2017 after the close of trading on Thursday, March 8, 2018. The Company’s management team will host a corresponding conference call beginning at 4:30 pm ET.

Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at www.chembio.com. A telephone replay will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 26056 until 4:30pm ET on Thursday, March 15, 2018.

Contact:
Lynn Pieper Lewis
Gilmartin Group
Investor Relations
(415) 937-5402
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring

Amazon Explores AI Content Marketplace With Media Publishers

Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion

Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units

U.S. Appeals Court Allows Trump Administration to End TPS for Honduras, Nepal, Nicaragua Migrants

Russia Condemns U.S. Sanctions as Cuba Faces Critical Fuel Crisis

U.S. Stock Futures Steady as Investors Await Key Jobs and Inflation Data

Hong Kong Leader Defends 20-Year Sentence for Jimmy Lai

India–US Trade Deal: Digital Tax Removal and $500 Billion Purchase Commitment Signal Major Policy Shift

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018

Editor's Picks

Welcome to EconoTimes